ReviewVeterinarni medicina2026
Effect of bacteriophages on growth performance and health indicators in broiler chickens in the absence of bacterial challenge - A review.
Review in Veterinarni medicina, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review examines bacteriophages as alternatives to antibiotic growth promoters (AGPs) in broiler chickens, with a unique focus on effects observed in studies without experimental bacterial challenges. Driven by global antimicrobial resistance (AMR) concerns and sustainable poultry production demands, phage supplementation, a targeted strategy, potentially improves growth performance and gut health by preserving beneficial microbiota. This literature analysis assesses phage efficacy in healthy broilers under non-challenge conditions, evaluating key variables such as phage concentration, delivery, and targets, as well as outcomes such as feed conversion ratio (FCR) and gut health markers. Crucially, this review extends beyond efficacy to explore phage immunomodulatory capabilities, outlines optimisation strategies, and addresses risks and mitigation. Key findings show mixed efficacy of phages in non-challenged broilers: significant improvements in FCR and gut health were generally observed with high phage concentrations (e.g., ≥10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.